Innate Immunity and Inflammation Laboratory, Instituto Gulbenkian de Ciência, 2780-156 Oeiras, Portugal.
Serviço de Cirurgia Geral, Hospital de São Bernardo-Centro Hospitalar de Setúbal EPE, 2910-446 Setúbal, Portugal.
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12281-12287. doi: 10.1073/pnas.1918508117. Epub 2020 May 18.
Sepsis is a life-threatening organ dysfunction condition caused by a dysregulated host response to an infection. Here we report that the circulating levels of growth and differentiation factor-15 (GDF15) are strongly increased in septic shock patients and correlate with mortality. In mice, we find that peptidoglycan is a potent ligand that signals through the TLR2-Myd88 axis for the secretion of GDF15, and that -deficient mice are protected against abdominal sepsis due to increased chemokine CXC ligand 5 (CXCL5)-mediated recruitment of neutrophils into the peritoneum, leading to better local bacterial control. Our results identify GDF15 as a potential target to improve sepsis treatment. Its inhibition should increase neutrophil recruitment to the site of infection and consequently lead to better pathogen control and clearance.
脓毒症是一种危及生命的器官功能障碍疾病,由宿主对感染的失调反应引起。在这里,我们报告说,在感染性休克患者中,生长分化因子 15(GDF15)的循环水平显著升高,并与死亡率相关。在小鼠中,我们发现肽聚糖是一种有效的配体,通过 TLR2-Myd88 轴信号传导,促进 GDF15 的分泌,而 GDF15 缺陷小鼠由于趋化因子 CXC 配体 5(CXCL5)介导的中性粒细胞向腹膜内募集增加而免受腹腔脓毒症的影响,从而导致更好的局部细菌控制。我们的研究结果表明,GDF15 是改善脓毒症治疗的一个潜在靶点。其抑制作用应增加中性粒细胞向感染部位的募集,从而导致更好的病原体控制和清除。